Top-News

SolarBank: Solarenergie… Die einmalige Gelegenheit in diesem Jahrzehnt(Anzeige)

Handeln

Innate Pharma News


2,215 €		+0,23%	+0,005 €

08:00:58 Uhr Gettex

aktualisieren | Orderbuch | Mehr Kurse »

WKN: A0LCUJ

ISIN: FR0010331421

US-Symbol: IPHYF

Typ: Aktie

Innate Pharma News

21.10.19 - GlobeNewswire

Innate Pharma Announces Closing of Global Offering

INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate Pharma ” or the “ Company ”), a French biotechnology company focused on discovering, ...

12.06.19 - GlobeNewswire

Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML

Multicohort, multi-center, international Phase II study to evaluate the efficacy and safety of IPH4102 in patients with advanced T-cell lymphoma is ongoing Sézary syndrome cohort of ...

31.05.19 - GlobeNewswire

Innate Pharma announces publication in Cell on innovative multifunctional NKp46 NK cell engagers (NKCEs)

The findings describe potential first-in-class NKp46 NKCEs, a new generation of multifunctional antibody-based molecules for fighting cancer The NKCE technology provides a ...

29.01.19 - GlobeNewswire

INNATE PHARMA RECEIVES FDA FAST TRACK DESIGNATION FOR IPH4102 IN RELAPSED OR REFRACTORY SÉZARY SYNDROME

INNATE PHARMA RECEIVES FDA FAST TRACK DESIGNATION FOR IPH4102 IN RELAPSED OR REFRACTORY SÉZARY SYNDROME

Newssuche

Videos

23.04.24 -3,35%

Technical Trading: S&P 500 Short Chance

S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Der KI-Boom ist vorbei!

Aber dieser heiße Sektor verspricht, weiter zu wachsen...
weiterlesen»

Anzeige